ENSP has launched the second Series of Fact Sheets covering a range of tobacco control topics. The latest 3 editions are dedicated to Tobacco Taxation, Emerging and Novel Tobacco Products and Impact of novel and emerging products AND youth.
Highligts:
Context: the tobacco epidemic in Europe
High prevalence: Compared to the rest of the world, the WHO Europe Region has the highest prevalence of tobacco smoking adults and among the highest smoking rates among adolescents.
High costs: Direct health costs: Tobacco-related disease
Indirect costs: Premature death, disability due to disease, decreased productivity
High morbidity and mortality: Tobacco use is estimated to be responsible for 16% of all deaths in adults above the age of 30 in the WHO Europe Region and a major contributor to socioeconomic disparity.
What are ‘novel tobacco products’?
According to the EU Tobacco Products Directive (2014/40/EU), a ‘novel tobacco product’ is defined as a tobacco product which does not fall into any of the following categories: cigarettes, roll-you-own tobacco, pipe tobacco, waterpipe tobacco, cigars, cigarillos, chewing tobacco, nasal tobacco or tobacco for oral use ; and was placed on the market after 19 May 2014.
Context: Secondhand Aerosol (SHA)
ENSP FACT SHEET ON TOBACCO TAXATION
ENSP FACT SHEET ON EMERGING AND NOVEL TOBACCO PRODUCTS
ENSP FACT SHEET ON IMPACT OF NOVEL AND EMERGING PRODUCTS AND YOUTH
Read again here the 2018 ENSP Fact Sheets Series.
From 21 to 23 September, the Portorož Youth Health Forum brings together youth workers, youth health advocates, health professionals, experts, and stakeholders from across Europe and beyond to explore the role...
Preparations are gaining momentum for the 11th European Conference on Tobacco Control (ECTC 2026), which will take place in Istanbul, Türkiye, from 4 to 6 November 2026. Held under...
The molecule behind 7 million deaths a year has never been regulated. A Pacific island nation of 18,000 is trying to change that Koror, Palau (June 10, 2026) — The...
